BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26045470)

  • 1. 15 YEARS OF PARAGANGLIOMA: Imaging and imaging-based treatment of pheochromocytoma and paraganglioma.
    Castinetti F; Kroiss A; Kumar R; Pacak K; Taieb D
    Endocr Relat Cancer; 2015 Aug; 22(4):T135-45. PubMed ID: 26045470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis, localization and treatment of pheochromocytoma in MEN 2 syndrome.
    Ilias I; Pacak K
    Endocr Regul; 2009 Apr; 43(2):89-93. PubMed ID: 19856714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and management of metastatic pheochromocytoma and paraganglioma].
    Jochmanová I; Lazúrová I
    Vnitr Lek; 2017; 63(9):580-588. PubMed ID: 29120654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary pheochromocytoma and paraganglioma.
    Mazzaglia PJ
    J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma.
    Janssen I; Blanchet EM; Adams K; Chen CC; Millo CM; Herscovitch P; Taieb D; Kebebew E; Lehnert H; Fojo AT; Pacak K
    Clin Cancer Res; 2015 Sep; 21(17):3888-95. PubMed ID: 25873086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pheochromocytoma and paraganglioma: basics for the general practitioner].
    Loosli N; Köhler BB; Pechère-Bertschi A; Karenovics W; Triponex F
    Rev Med Suisse; 2014 Sep; 10(441):1650-2, 1654-5. PubMed ID: 25322623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic pheochromocytoma and paraganglioma.
    Angelousi A; Kassi E; Zografos G; Kaltsas G
    Eur J Clin Invest; 2015 Sep; 45(9):986-97. PubMed ID: 26183460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics, diagnosis, and management of medullary thyroid carcinoma and pheochromocytoma/paraganglioma.
    Moraitis AG; Martucci VL; Pacak K
    Endocr Pract; 2014 Feb; 20(2):176-87. PubMed ID: 24449662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical management of paragangliomas.
    Corssmit EP; Romijn JA
    Eur J Endocrinol; 2014 Dec; 171(6):R231-43. PubMed ID: 25063320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pheochromocytoma and abdominal paraganglioma.
    Renard J; Clerici T; Licker M; Triponez F
    J Visc Surg; 2011 Dec; 148(6):e409-16. PubMed ID: 21862435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pediatric pheochromocytoma and paraganglioma: an update].
    Garnier S; Réguerre Y; Orbach D; Brugières L; Kalfa N
    Bull Cancer; 2014 Oct; 101(10):966-75. PubMed ID: 25373696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel liquid biopsy (NETest) identifies paragangliomas and pheochromocytomas with high accuracy.
    Pacak K; Kidd M; Meuter L; Modlin IM
    Endocr Relat Cancer; 2021 Oct; 28(11):731-744. PubMed ID: 34515661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of pheochromocytoma with special emphasis on MEN2 syndrome.
    Pacak K; Eisenhofer G; Ilias I
    Hormones (Athens); 2009; 8(2):111-6. PubMed ID: 19570738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular imaging and theranostic approaches in pheochromocytoma and paraganglioma.
    Taïeb D; Pacak K
    Cell Tissue Res; 2018 May; 372(2):393-401. PubMed ID: 29450723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant pheochromocytomas and paragangliomas - the importance of a multidisciplinary approach.
    Andersen KF; Altaf R; Krarup-Hansen A; Kromann-Andersen B; Horn T; Christensen NJ; Hendel HW
    Cancer Treat Rev; 2011 Apr; 37(2):111-9. PubMed ID: 20675056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience.
    De Filpo G; Cantini G; Rastrelli G; Vannini G; Ercolino T; Luconi M; Mannelli M; Maggi M; Canu L
    J Endocrinol Invest; 2022 Jan; 45(1):149-157. PubMed ID: 34227051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (11)C-hydroxyephedrine positron emission tomography in the postoperative management of pheochromocytoma and paraganglioma.
    Yamamoto S; Wassberg C; Hellman P; Sundin A
    Neuroendocrinology; 2014; 100(1):60-70. PubMed ID: 25012453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and future anatomical and functional imaging approaches to pheochromocytoma and paraganglioma.
    Timmers HJ; Taieb D; Pacak K
    Horm Metab Res; 2012 May; 44(5):367-72. PubMed ID: 22399235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant pheochromocytomas and paragangliomas: a diagnostic challenge.
    Gimm O; DeMicco C; Perren A; Giammarile F; Walz MK; Brunaud L
    Langenbecks Arch Surg; 2012 Feb; 397(2):155-77. PubMed ID: 22124609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pheochromocytomas and Hypertension.
    Pappachan JM; Tun NN; Arunagirinathan G; Sodi R; Hanna FWF
    Curr Hypertens Rep; 2018 Jan; 20(1):3. PubMed ID: 29356966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.